In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - SPOC-2012-001
Protocol Summary
- Protocol No
- SPOC-2012-001
- Principal Investigator
- Paul Harker-Murray
- Phase
- I
- Title
- Phase 1 Dose-Escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Associated Disease(s)
-
Early Phase Trials (Phase I and II)
- Description (Summary)
- The main purpose of this study is to determine whether the combination of MM-398 and Cyclophosphamide is safe and effective in patients with certain recurrent or refractory solid tumors. We are studying the biology and drug side effects in patients treated with MM-398.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
